The placenta appears to contribute to the pathogenesis of GDM as it affects insulin resistance progression, and its delivery during labor seems to improve glucose metabolism, which is reflected in the reduced demands for the insulin used to treat GDM shortly after delivery [28]. This evidence concerns the gene INS and gestational diabetes.